LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
- Your personalised programme is built around medical care, not willpower.
- No generic diets. No guesswork.
- Just science-backed results and expert support.
Find out if you’re eligible
Does Ozempic make you gassy? Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus. Gastrointestinal side effects, including gas, bloating, and abdominal distension, are among the most commonly reported adverse reactions. These symptoms typically occur during initial treatment or following dose increases and often improve as the body adjusts. Whilst not everyone experiences these effects, understanding why they occur and how to manage them can help you continue treatment safely. If symptoms persist or worsen, discuss them with your GP or diabetes specialist nurse for tailored advice.
Quick Answer: Ozempic commonly causes gas and bloating, particularly during initial treatment or dose increases, though symptoms typically improve over time as the body adjusts.
Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus. Whilst it is highly effective at improving glycaemic control, gastrointestinal side effects are the most frequently reported adverse reactions. Gas, bloating, and abdominal distension affect a significant proportion of patients, particularly during the initial weeks of treatment or following dose escalation.
According to the UK SmPC (Summary of Product Characteristics), gastrointestinal symptoms are common, with nausea occurring in up to 20% of patients, diarrhoea in approximately 12%, and vomiting in around 9%. Flatulence and abdominal distension are also listed as common side effects. These symptoms tend to be mild to moderate in severity, and most patients experience improvement over time as the body adjusts to the medication.
It is important to note that not everyone will experience these side effects, and individual tolerance varies considerably. Factors such as baseline gastrointestinal health, dietary habits, dose titration speed, and concurrent medications may influence symptom severity. If you are experiencing persistent or troublesome gas and bloating whilst taking Ozempic, it is advisable to discuss this with your GP or diabetes specialist nurse. They can assess whether the symptoms are related to the medication and provide tailored advice on management strategies.
Whilst gas and bloating are recognised side effects, they do not typically necessitate discontinuation of treatment. However, seek urgent medical attention if you experience severe, persistent abdominal pain (especially if radiating to the back) with or without vomiting (possible pancreatitis), right-upper-quadrant pain/fever/jaundice (possible gallbladder disease), severe abdominal distension with constipation/vomiting (possible intestinal obstruction), or signs of dehydration such as dizziness or reduced urination.
If you suspect you are experiencing side effects from Ozempic, you can report them via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app).
LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
Find out if you’re eligible
Understanding the mechanism of action of Ozempic helps explain why gastrointestinal side effects, including gas and bloating, are so common. Semaglutide is a GLP-1 receptor agonist that mimics the action of the naturally occurring incretin hormone GLP-1. This hormone plays a crucial role in glucose homeostasis by enhancing insulin secretion in a glucose-dependent manner, suppressing glucagon release, and thereby indirectly reducing hepatic glucose production.
Crucially, GLP-1 receptors are also present throughout the gastrointestinal tract, where they exert significant effects on gut motility. Semaglutide slows gastric emptying, meaning food remains in the stomach for longer before passing into the small intestine. This delayed transit can lead to feelings of fullness, early satiety, and reduced appetite—effects that contribute to the weight reduction often observed with treatment, though it's important to note that Ozempic is not licensed for weight management in the UK (Wegovy is the brand of semaglutide licensed for weight management).
The slowed gastrointestinal transit can contribute to bloating and gas accumulation. When food moves more slowly through the intestines, there may be increased opportunity for bacterial fermentation of undigested carbohydrates in the colon, potentially leading to greater gas production. The relationship between GLP-1 receptor agonists and changes to the gut microbiome is an emerging area of research, though not yet fully established.
The dose-dependent nature of these effects is well recognised. According to the UK SmPC, patients typically start on a low dose (0.25 mg once weekly) with gradual titration to therapeutic doses (0.5 mg, 1 mg, or 2 mg weekly). Gastrointestinal side effects are most pronounced during the initial weeks and following dose increases, often improving as the body adapts. It's worth noting that the gastric emptying effect tends to attenuate over time with continued treatment.
Semaglutide should be used with caution in patients with pre-existing gastrointestinal disorders and is not recommended in those with severe gastroparesis or other severe gastrointestinal diseases.
If you are experiencing gas and bloating whilst taking Ozempic, several practical strategies can help alleviate symptoms without compromising treatment efficacy. Dietary modification is often the first-line approach and can yield significant improvements.
Dietary adjustments include:
Eating smaller, more frequent meals rather than large portions, which can overwhelm the already slowed digestive system
Reducing intake of gas-producing foods such as beans, lentils, cruciferous vegetables (broccoli, cauliflower, cabbage), onions, and carbonated beverages
Limiting high-fat foods, as these delay gastric emptying further and may worsen bloating
Avoiding artificial sweeteners (sorbitol, mannitol, xylitol) found in sugar-free products, which can ferment in the gut
Chewing food thoroughly and eating slowly to reduce air swallowing (aerophagia)
Staying well hydrated, particularly if constipation is contributing to gas and bloating
Lifestyle measures can also be beneficial. Regular physical activity, even gentle walking after meals, promotes gut motility and can help relieve trapped gas. Maintaining a consistent meal schedule supports digestive regularity.
Some patients find over-the-counter remedies helpful, such as simethicone (which breaks down gas bubbles) or peppermint oil capsules (which may ease bloating). However, peppermint oil should be avoided if you have reflux or a hiatus hernia as it may worsen symptoms. If constipation is contributing to your gas and bloating, gradual fibre adjustments with adequate fluid intake may help; in some cases, osmotic laxatives like macrogol might be appropriate after discussion with a healthcare professional.
Probiotics are sometimes suggested, though evidence for their efficacy specifically for GLP-1 agonist-related gas is limited. If you wish to try them, consider a time-limited trial to assess benefits. Always inform your GP or pharmacist before starting any new supplements, as interactions with other medications should be considered.
If symptoms persist despite these measures, your healthcare provider may consider temporarily reducing the Ozempic dose or slowing the titration schedule. In some cases, switching to an alternative GLP-1 receptor agonist with a different pharmacokinetic profile may be appropriate. Never adjust your dose without medical supervision.
Seek medical advice if your symptoms persist or worsen despite these self-care measures.
If gastrointestinal side effects from Ozempic are significantly impacting your quality of life despite management strategies, it is important to have an open discussion with your GP or diabetes specialist. There are several alternative treatment options for type 2 diabetes that may be considered, depending on your individual circumstances, glycaemic control, cardiovascular risk profile, and treatment goals.
Alternative GLP-1 receptor agonists include dulaglutide, liraglutide, and exenatide. Whilst these medications share a similar mechanism of action and side effect profile, individual tolerance can vary. Some patients who experience troublesome symptoms with one GLP-1 agonist may tolerate another better. Your clinician can advise whether a trial of an alternative agent is appropriate.
Other glucose-lowering medication classes that may be considered include:
SGLT2 inhibitors (e.g., dapagliflozin, empagliflozin), which offer cardiovascular and renal benefits with a different side effect profile (primarily genital infections and increased urination). Be aware that these carry a small risk of euglycaemic diabetic ketoacidosis
DPP-4 inhibitors (e.g., sitagliptin, linagliptin), which are generally well tolerated but less effective for weight reduction
Metformin, if not already prescribed, remains the first-line oral agent for type 2 diabetes, though it can also cause gastrointestinal upset
Insulin therapy, which may be necessary if oral agents and GLP-1 agonists are not tolerated or insufficient, though this carries a risk of hypoglycaemia
When discussing alternatives with your GP, consider bringing up:
The severity and duration of your symptoms
Any dietary or lifestyle modifications you have already tried
Your treatment priorities (e.g., cardiovascular protection, convenience)
Other medical conditions or medications that may influence treatment choice
NICE guidance (NG28) recommends individualised treatment approaches for type 2 diabetes, taking into account patient preferences, comorbidities, and tolerability. Your healthcare team should work collaboratively with you to find the most suitable regimen that balances efficacy with acceptable side effects.
Gas and bloating from Ozempic are most common during the first few weeks of treatment and following dose increases. These symptoms typically improve over time as your body adjusts to the medication, though individual experiences vary.
Over-the-counter remedies such as simethicone or peppermint oil capsules may help relieve gas and bloating. However, always inform your GP or pharmacist before starting any new supplements to ensure they are appropriate for your circumstances and do not interact with other medications.
Contact your GP if symptoms persist despite dietary and lifestyle modifications, or seek urgent medical attention if you experience severe persistent abdominal pain, signs of pancreatitis, gallbladder disease, intestinal obstruction, or dehydration.
All medical content on this blog is created based on reputable, evidence-based sources and reviewed regularly for accuracy and relevance. While we strive to keep content up to date with the latest research and clinical guidelines, it is intended for general informational purposes only.
DisclaimerThis content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional with any medical questions or concerns. Use of the information is at your own risk, and we are not responsible for any consequences resulting from its use.
